Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2953)
All Articles published online
|
Feb 7, 2010 (publication date) through Jun 5, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Han T, Liu Y, Liu H, Zhu ZY, Li Y, Xiao SX, Guo Z, Zhao ZG. Serum thymosin β4 levels in patients with hepatitis B virus-related liver failure. World J Gastroenterol 2010; 16(5): 625-630 [PMID: 20128033 DOI: 10.3748/wjg.v16.i5.625] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i5/625.htm |
| Number | Citing Articles |
| 1 |
Jing Liang, Wenjuan Cai, Tao Han, Li Jing, Zhe Ma, Yingtang Gao. The expression of thymosin β4 in chronic hepatitis B combined nonalcoholic fatty liver disease. Medicine 2016; 95(52): e5763 doi: 10.1097/MD.0000000000005763
|
| 2 |
Xiaoming Chen, Fangjie Wo, Jiang Chen, Jie Tan, Tao Wang, Xiao Liang, Jianmin Wu. Ratiometric Mass Spectrometry for Cell Identification and Quantitation Using Intracellular “Dual-Biomarkers”. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-17812-1
|
| 3 |
Fizzah A Choudry, Chia Yeo, Abdul Mozid, John F Martin, Anthony Mathur. Increases in Plasma Tβ4 after Intracardiac Cell Therapy in Chronic Ischemic Heart Failure is Associated with Symptomatic Improvement. Regenerative Medicine 2015; 10(4): 403 doi: 10.2217/rme.15.9
|
| 4 |
Mohamed A. A. Hussein, Hosni A. M. Hussein, Ali A. Thabet, Karim M. Selim, Mervat A. Dawood, Ahmed M. El-Adly, Ahmed A. Wardany, Ali Sobhy, Sameh Magdeldin, Aya Osama, Ali M. Anwar, Mohammed Abdel-Wahab, Hussam Askar, Elsayed K. Bakhiet, Serageldeen Sultan, Amgad A. Ezzat, Usama Abdel Raouf, Magdy M. Afifi. Human Wharton’s Jelly Mesenchymal Stem Cells Secretome Inhibits Human SARS-CoV-2 and Avian Infectious Bronchitis Coronaviruses. Cells 2022; 11(9): 1408 doi: 10.3390/cells11091408
|
| 5 |
G. Sosne, D. Rimmer, H.K. Kleinman, G. Ousler. Thymosins. Vitamins and Hormones 2016; 102: 277 doi: 10.1016/bs.vh.2016.04.012
|
| 6 |
He Wang, Yan-Ping Yin, Zhen-Li Wang, Yu Qian, Yu-Chen Fan, Hui-Hui Liu, Kai Wang. Hypermethylation of thymosin β4 predicts a poor prognosis for patients with acute-on-chronic hepatitis B liver failure. Hepatobiliary & Pancreatic Diseases International 2023; 22(4): 373 doi: 10.1016/j.hbpd.2022.08.005
|
| 7 |
Kama A. Wlodzimirow, Saeid Eslami, Ameen Abu‐Hanna, Martin Nieuwoudt, Robert A. F. M. Chamuleau. A systematic review on prognostic indicators of acute on chronic liver failure and their predictive value for mortality. Liver International 2013; 33(1): 40 doi: 10.1111/j.1478-3231.2012.02790.x
|
| 8 |
Zhe-Bin Wu, Yu-Bao Zheng, Ke Wang, Zhi-Shuo Mo, Xu Zhen, Ying Yan, Zhi-Liang Gao, Yu-Chen Fan. Plasma Interleukin-6 Level: A Potential Prognostic Indicator of Emergent HBV-Associated ACLF. Canadian Journal of Gastroenterology and Hepatology 2021; 2021: 1 doi: 10.1155/2021/5545181
|
| 9 |
Jieun Kim, Sihyung Wang, Jeongeun Hyun, Steve S. Choi, Heejae Cha, Meesun Ock, Youngmi Jung, Michel Samson. Hepatic Stellate Cells Express Thymosin Beta 4 in Chronically Damaged Liver. PLOS ONE 2015; 10(3): e0122758 doi: 10.1371/journal.pone.0122758
|
| 10 |
Kyung Sook Cho, Dong-Jin Kim, Bomee Shim, Jung Yeon Kim, Jun Mo Kang, Seon Hwa Park, Sang-Ho Lee, Hyung-In Yang, Kyoung Soo Kim. An Investigation on the Therapeutic Effect of Thymosinβ4 and Its Expression Levels in Streptozotocin-Induced Diabetic Mice. BioMed Research International 2018; 2018: 1 doi: 10.1155/2018/3421568
|
| 11 |
Karina Reyes-Gordillo, Ruchi Shah, Anastas Popratiloff, Sidney Fu, Anna Hindle, Frederick Brody, Marcos Rojkind. Thymosin-β4 (Tβ4) Blunts PDGF-Dependent Phosphorylation and Binding of AKT to Actin in Hepatic Stellate Cells. The American Journal of Pathology 2011; 178(5): 2100 doi: 10.1016/j.ajpath.2011.01.025
|
| 12 |
Min Wei, Dongmei Duan, Yujie Liu, Zhigang Wang, Zhongli Li. Increased thymosin β4 levels in the serum and SF of knee osteoarthritis patients correlate with disease severity. Regulatory Peptides 2013; 185: 34 doi: 10.1016/j.regpep.2013.06.011
|
| 13 |
Asuman Biçer, Özlem Karakurt, Ramazan Akdemir, Gönül Erden, Ali Yildiz, Özge Özcan, Yusuf Sezen, Sadik Açikel, Harun Kiliç, Recep DemirbaG. Thymosin beta 4 is associated with collateral development in coronary artery disease. Scandinavian Journal of Clinical and Laboratory Investigation 2011; 71(8): 625 doi: 10.3109/00365513.2011.599417
|
| 14 |
Yongqiang Liao, Ni Xiao, Xiaoming Wang, Senhua Dai, Guiliang Wang. Promoting effect of Tmsb4x on the differentiation of peripheral blood mononuclear cells to dendritic cells during septicemia. International Immunopharmacology 2022; 111: 109002 doi: 10.1016/j.intimp.2022.109002
|
| 15 |
Ying Liu, Tao Han, Zheng-yan Zhu, Ying Li. Thymosinβ4: A novel assessed biomarker of the prognosis of acute-on-chronic liver failure patient?. Clinics and Research in Hepatology and Gastroenterology 2014; 38(3): 310 doi: 10.1016/j.clinre.2014.02.004
|
| 16 |
Hanchao Li, Qian Li, Xueting Zhang, Xiaoyan Zheng, Qiannan Zhang, Zhiming Hao. Thymosin β4 suppresses CCl4‐induced murine hepatic fibrosis by down‐regulating transforming growth factor β receptor‐II. The Journal of Gene Medicine 2018; 20(9) doi: 10.1002/jgm.3043
|
| 17 |
He Wang, Yu Qian, Jing-Wen Wang, Yu Fang, Yu-Chen Fan, Hui-Hui Liu, Kai Wang. Hypomethylation of thymosin β4 promoter is associated with glucocorticoid therapy in patients with acute-on-chronic hepatitis B-induced liver failure. International Health 2023; 15(1): 19 doi: 10.1093/inthealth/ihac003
|
| 18 |
Zhen Tian, Naijuan Yao, Fei Wang, Litao Ruan. Thymosin β4 Suppresses LPS-Induced Murine Lung Fibrosis by Attenuating Oxidative Injury and Alleviating Inflammation. Inflammation 2022; 45(1): 59 doi: 10.1007/s10753-021-01528-6
|
| 19 |
Fei Wang, Yajuan He, Naijuan Yao, Litao Ruan, Zhen Tian, Abdel A. Abdel-Rahman. Thymosin β4 Protects against Cardiac Damage and Subsequent Cardiac Fibrosis in Mice with Myocardial Infarction. Cardiovascular Therapeutics 2022; 2022: 1 doi: 10.1155/2022/1308651
|
| 20 |
Rui Yu, Yunyun Mao, Kai Li, Yanfang Zhai, Yue Zhang, Shuling Liu, Yuemei Gao, Zhengshan Chen, Yanhong Liu, Ting Fang, Mengsu Zhao, Ruihua Li, Junjie Xu, Wei Chen, Yaoyao Xia. Recombinant Human Thymosin Beta-4 Protects against Mouse Coronavirus Infection. Mediators of Inflammation 2021; 2021: 1 doi: 10.1155/2021/9979032
|
| 21 |
Hynda K. Kleinman, Veronika Kulik, Allan L. Goldstein. Thymosin β4 and the anti-fibrotic switch. International Immunopharmacology 2023; 115: 109628 doi: 10.1016/j.intimp.2022.109628
|
| 22 |
S. Tsiomita, U. Georgopoulou, P.P. Doumba, J. Koskinas, K. Adamidis, C. Papaloukas, G. Thyphronitis. Evaluation of alternative serum biomarkers to monitor the progression of chronic HBV and HCV infection. Infection, Genetics and Evolution 2018; 58: 17 doi: 10.1016/j.meegid.2017.12.002
|
| 23 |
Yuheng Hong, Qingbin Yao, Lina Zheng. Thymosin β4 attenuates liver fibrosis via suppressing Notch signaling. Biochemical and Biophysical Research Communications 2017; 493(4): 1396 doi: 10.1016/j.bbrc.2017.09.156
|
| 24 |
Allan L Goldstein, Ewald Hannappel, Gabriel Sosne, Hynda K Kleinman. Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications. Expert Opinion on Biological Therapy 2012; 12(1): 37 doi: 10.1517/14712598.2012.634793
|
| 25 |
Song-Song Zou, Jing Wang, Bao-Xia Li, Gui-Wen Yang, Jie-Jie Sun, Hui-Ting Yang. Thymosin participates in antimicrobial immunity in zebrafish. Fish & Shellfish Immunology 2019; 87: 371 doi: 10.1016/j.fsi.2019.01.040
|
| 26 |
Li Yang, Wei-li Fu, Ying Zhu, Xiao-guang Wang. Tβ4 suppresses lincRNA-p21-mediated hepatic apoptosis and fibrosis by inhibiting PI3K-AKT-NF-κB pathway. Gene 2020; 758: 144946 doi: 10.1016/j.gene.2020.144946
|